RxSight, Inc. (RXST) insider buying and SEC filings
RxSight, Inc. · CIK 1111485
Tracked: Forms 3/4/5, 8-K, NT · All filings on sec.gov
Company profile
- Exchanges
- Nasdaq
- Industry (SIC)
- Ophthalmic Goods
- State of incorporation
- DE
- Fiscal year end
- Dec 31
- Former names
- CALHOUN VISION INC
Insider activity in the last 12 months
Bought
$0
Insiders who bought
0
Sold (not marked 10b5-1)
$118K
Planned sales (10b5-1)
$0
Insider purchases and sales, last 12 months
| Traded | Type | What was filed | Source |
|---|---|---|---|
| Sep 2, 2026 | Sale | Ronald M MD Kurtz (Chief Medical Officer) sold 5,100 shares at $6.96 ($35K). Holdings down 7% to 71,775 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Sep 2, 2026 |
| Sep 2, 2026 | Sale | Mark Wilterding (CFO) sold 7,765 shares at $6.96 ($54K). Holdings down 24% to 25,049 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Sep 2, 2026 |
| Sep 2, 2026 | Sale | Ilya Goldshleger (President / COO) sold 2,041 shares at $6.96 ($14K). Holdings down 2% to 81,509 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Sep 2, 2026 |
| Sep 2, 2026 | Sale | Eric Weinberg (Chief Business Development Officer) sold 2,041 shares at $6.96 ($14K). Holdings down 1% to 200,348 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Sep 2, 2026 |
26 routine transactions (such as grants, option exercises or tax withholding) are not listed.
Cluster buys
No cluster buys in the last 12 months.
Red flags
No red flags in the last 12 months.
Key events
No key events in the last 12 months.
8-K filings, last 12 months
| Filed | Items | Tag | Source |
|---|---|---|---|
| Nov 3, 2026, 4:05 PM ET 8-K | Earnings released (Item 2.02) | SEC filing |
Red flags are objective triggers only: the item or form filed, never an opinion.
Follow RXST in the Insider Ledger app
Get the appA plain-English brief of insider purchases, 8-Ks and red flags at the companies you pick. No account needed.